Back

An Erg driven transcriptional program controls B-lymphopoiesis

Ng, A. P.; Coughlan, H. D.; Hediyeh-zadeh, S.; Behrens, K.; Johanson, T. M.; Low, M. S. Y.; Bell, C. C.; Gilan, O.; Chan, Y.-C.; Kueh, A. J.; Boudier, T.; DiRago, L.; Hyland, C. D.; Ierino, H.; Mifsud, S.; Viney, E.; Willson, T.; Dawson, M. A.; Allan, R. S.; Herold, M. J.; Rogers, K.; Tarlinton, D. M.; Smyth, G.; Davis, M. J.; Nutt, S. L.; Alexander, W. S.

2019-12-03 immunology
10.1101/861542 bioRxiv
Show abstract

Summary/AbstractB-cell development is initiated by the stepwise differentiation of hematopoietic stem cells into lineage committed progenitors, ultimately generating the mature B-cells that mediate protective immunity. This highly regulated process also generates clonal immunological diversity via recombination of immunoglobulin genes. While several transcription factors that control B-cell development and V(D)J recombination have been defined, how these processes are initiated and coordinated into a precise regulatory network remains poorly understood. Here, we show that the transcription factor ETS Related Gene (Erg) is essential for the earliest steps in B-cell differentiation. Erg initiates a transcriptional network involving the B-cell lineage defining genes, Ebf1 and Pax5, that directly promotes the expression of key genes involved in V(D)J recombination and formation of the B-cell receptor. Complementation of the Erg-deficiency with a productively rearranged immunoglobulin gene rescued B-cell development, demonstrating that Erg is an essential and exquisitely stage specific regulator of the gene regulatory network controlling B-lymphopoiesis.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
eLife
5828 papers in training set
Top 4%
15.4%
2
Nature Communications
5641 papers in training set
Top 13%
13.1%
3
Cell Reports
1498 papers in training set
Top 3%
8.0%
4
Blood
74 papers in training set
Top 0.3%
6.9%
5
The Journal of Immunology
166 papers in training set
Top 0.4%
6.9%
50% of probability mass above
6
Nature Immunology
79 papers in training set
Top 0.4%
6.4%
7
Immunology & Cell Biology
11 papers in training set
Top 0.1%
3.3%
8
Frontiers in Immunology
638 papers in training set
Top 4%
3.3%
9
Blood Advances
62 papers in training set
Top 0.5%
3.3%
10
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 20%
2.7%
11
iScience
1154 papers in training set
Top 10%
2.5%
12
Journal of Experimental Medicine
119 papers in training set
Top 1%
2.4%
13
Science Advances
1243 papers in training set
Top 16%
2.2%
14
Communications Biology
993 papers in training set
Top 12%
1.9%
15
Science Immunology
88 papers in training set
Top 1%
1.9%
16
Life Science Alliance
285 papers in training set
Top 3%
1.9%
17
Scientific Reports
3612 papers in training set
Top 58%
1.5%
18
Nature
645 papers in training set
Top 9%
1.1%
19
Immunity
67 papers in training set
Top 2%
0.9%
20
EMBO Reports
263 papers in training set
Top 7%
0.9%
21
Development
497 papers in training set
Top 5%
0.9%
22
Nucleic Acids Research
1281 papers in training set
Top 14%
0.6%
23
PLOS Pathogens
820 papers in training set
Top 10%
0.6%
24
PLOS Genetics
862 papers in training set
Top 13%
0.6%
25
Leukemia
42 papers in training set
Top 0.8%
0.6%